Pharmacologic manipulation of steroid hormones. Adjunctive therapies in cancer of the breast

Andrea Manni

doi:10.1016/s0889-8529(18)30246-9

Pharmacologic manipulation of steroid hormones. Adjunctive therapies in cancer of the breast

Andrea Manni

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Abstract

Tamoxifen is the endocrine treatment of choice for hormone-responsive early and advanced breast cancer. Newly developed biodegradable luteinizing hormone-releasing hormone super agonists represent a practical and effective treatment for metastatic disease in premenopausal women. Progestins or aromatase inhibitors are useful therapies in patients who relapse from antiestrogens. Currently, there is no indication that improved survival can be achieved by combined endocrine therapy or combined chemo-hormonal therapy.

Original language	English (US)
Pages (from-to)	825-844
Number of pages	20
Journal	Endocrinology and Metabolism Clinics of North America
Volume	20
Issue number	4
DOIs	https://doi.org/10.1016/s0889-8529(18)30246-9
State	Published - 1991

All Science Journal Classification (ASJC) codes

Endocrinology, Diabetes and Metabolism
Endocrinology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/s0889-8529(18)30246-9

Cite this

@article{19423921cfed46cfbe7e28a4dc0669ee,

title = "Pharmacologic manipulation of steroid hormones. Adjunctive therapies in cancer of the breast",

abstract = "Tamoxifen is the endocrine treatment of choice for hormone-responsive early and advanced breast cancer. Newly developed biodegradable luteinizing hormone-releasing hormone super agonists represent a practical and effective treatment for metastatic disease in premenopausal women. Progestins or aromatase inhibitors are useful therapies in patients who relapse from antiestrogens. Currently, there is no indication that improved survival can be achieved by combined endocrine therapy or combined chemo-hormonal therapy.",

author = "Andrea Manni",

year = "1991",

doi = "10.1016/s0889-8529(18)30246-9",

language = "English (US)",

volume = "20",

pages = "825--844",

journal = "Endocrinology and Metabolism Clinics of North America",

issn = "0889-8529",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Pharmacologic manipulation of steroid hormones. Adjunctive therapies in cancer of the breast

AU - Manni, Andrea

PY - 1991

Y1 - 1991

N2 - Tamoxifen is the endocrine treatment of choice for hormone-responsive early and advanced breast cancer. Newly developed biodegradable luteinizing hormone-releasing hormone super agonists represent a practical and effective treatment for metastatic disease in premenopausal women. Progestins or aromatase inhibitors are useful therapies in patients who relapse from antiestrogens. Currently, there is no indication that improved survival can be achieved by combined endocrine therapy or combined chemo-hormonal therapy.

AB - Tamoxifen is the endocrine treatment of choice for hormone-responsive early and advanced breast cancer. Newly developed biodegradable luteinizing hormone-releasing hormone super agonists represent a practical and effective treatment for metastatic disease in premenopausal women. Progestins or aromatase inhibitors are useful therapies in patients who relapse from antiestrogens. Currently, there is no indication that improved survival can be achieved by combined endocrine therapy or combined chemo-hormonal therapy.

UR - http://www.scopus.com/inward/record.url?scp=0026345693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026345693&partnerID=8YFLogxK

U2 - 10.1016/s0889-8529(18)30246-9

DO - 10.1016/s0889-8529(18)30246-9

M3 - Review article

C2 - 1778179

AN - SCOPUS:0026345693

SN - 0889-8529

VL - 20

SP - 825

EP - 844

JO - Endocrinology and Metabolism Clinics of North America

JF - Endocrinology and Metabolism Clinics of North America

IS - 4

ER -

Pharmacologic manipulation of steroid hormones. Adjunctive therapies in cancer of the breast

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this